Arca Biopharma (ABIO) soars 35% premarket. The company says it will collaborate with Medtronic...

|By:, SA News Editor

Arca Biopharma (ABIO) soars 35% premarket. The company says it will collaborate with Medtronic (MDT) on a Phase 2b clinical trial for Gencaro, ABIO's lead developmental drug for the treatment of cardiac rhythm disorders.